<?xml version="1.0" encoding="UTF-8"?>
<ref id="B146-pharmaceuticals-12-00157">
 <label>146.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bruzzoni-Giovanelli</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Alezra</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Wolff</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Dong</surname>
    <given-names>C.Z.</given-names>
   </name>
   <name>
    <surname>Tuffery</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Rebollo</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Interfering peptides targeting protein-protein interactions: The next generation of drugs?</article-title>
  <source>Drug Discov. Today</source>
  <year>2018</year>
  <volume>3</volume>
  <fpage>272</fpage>
  <lpage>285</lpage>
  <pub-id pub-id-type="doi">10.1016/j.drudis.2017.10.016</pub-id>
 </element-citation>
</ref>
